Patel P,McAuslane JAN, Liberti L. Agency activity and company strategy –How are these influencing time to market for new medicines in the emerging markets? Washington,DC: Annual Meeting of the Drug Information Association, June 2010.
Meister G, Yuvasheva E. The impact of FDA priority, accelerated, and fast-track reviews on approval times and postapproval regulatory activity. Poster presentation; Chicago, Illinois: Annual Drug Information Association Meeting, June 2011.
Al-Rubaie M, Salek S, Walker S. Comparisons of the Gulf States’ and pharmaceutical companies’ perspectives on the effectiveness of the GCC centralised procedure. Poster presentation; Chicago, Illinois: Annual Drug Information Association Meeting, June, 2011.
Pichler F, Wang T. Benchmarking time and process in HTA and decision making. Poster presentation, Rio de Janeiro, Brazil: Health Technology Assessment International Annual Conference, June 2011.